Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 15Unknown 8Recruiting 4Not yet recruiting 3Terminated 2Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 1131Neoplasms 986Carcinoma, Non-Small-Cell Lung 903Prostatic Neoplasms 595Neoplasm Metastasis 529Leukemia, Myeloid, Acute 514Colorectal Neoplasms 492Lung Neoplasms 490Melanoma 488Multiple Myeloma 478Pancreatic Neoplasms 387Lymphoma 370Ovarian Neoplasms 368Recurrence 365Lymphoma, Non-Hodgkin 348Leukemia 340Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Head and Neck Neoplasms 276Carcinoma, Renal Cell 276Brain Neoplasms 276Carcinoma, Hepatocellular 261Glioblastoma 250Myelodysplastic Syndromes 244Lymphoma, Large B-Cell, Diffuse 244Squamous Cell Carcinoma of Head and Neck 241Lymphoma, Follicular 236Colonic Neoplasms 214Stomach Neoplasms 200Rectal Neoplasms 190

Interventions

Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hematuria × Clear all
NCT01563796 2025-09-26

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Medical Diagnostic Laboratories, LLC

Terminated
1,115 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Dysuria

NCT02350543 2019-04-08

Peri-operative Aspirin Continuation Versus Discontinuation

Rabin Medical Center

Phase 4 Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria

Data powered by HemOnc (CC BY 4.0) Colophon âš¡